• The meeting will cover the following main topics (in alphabetical order):
  • Animal lectins
  • Biosynthesis & Metabolism of Glycoconjugates
  • Cell Biology of Protein Glycosylation
  • Comparative and evolutionary glycobiology
  • Developmental & Stem Cell Biology
  • General Glycoscience
  • Genetics and epigenetics of protein glycosylation
  • Glycans and cancer
  • Glycans in signaling and cellular communication
  • Glyco(bio)informatics
  • Glyco(bio)technology
  • Glyco(proteo)mics
  • Glycobiology of autoimmune and inflammatory diseases
  • Glycobiology of infectious disease
  • Glycoimmunology
  • Glycolipids, membrane domains and cell signaling
  • Glycoproteins and Glycolipids in Disease
  • Glycosylation in bacteria
  • Intestinal glycoscience
  • Neuroglycoscience
  • Proteoglycans
  • Structural & Chemical Glycobiology
  • In addition, four special sessions will be organized:
  • Guest session of the Society for Glycobiology
  • Guest Session of the Asian Community for Glycoscience and Glycobiotechnology
  • Pre-symposium training course “Introduction to Glycoscience”
  • Young glycoscientists' symposium

Plenary Lecturers

  • Nico Callewaert (VIB and Ghent University; Ghent, Belgium)
    Glycan customization for optimizing biopharmaceutical properties
  • Jin Won Cho (Yonsei University; Seoul, Korea)
    Identification of NLS and molecular mechanism of O-GlcNAc transferase translocation into nucleus
  • Max  Crispin (University of Oxford; Oxford, United Kingdom)
    The structure and organisation of the glycan shield of HIV
  • Anne Dell (Imperial College London; London, United Kingdom)
     High sensitivity Glycomics: Windows to Glycan function
  • Koichi Furukawa (Nagoya University Graduate School of Medicine; Nagoya, Japan)
    Novel functions and mechanisms of complex carbohydrates elucidated by
    glycosyltransferase gene knockout
  • John A. Hanover (National Institutes of Health, MD, USA)
    A little sugar goes a long way: O-GlcNAc and epigenetics
  • Jamey Marth (University of California Santa Barbara; Santa Barbara, CA, USA)
    Overlapping mechanisms of sepsis, inflammatory bowel disease, and diabetes
  • Pauline Rudd (NIBRT; Dublin, Ireland)
    Glycoscience and the systems biology of cancer
  • Robert Sackstein (Harvard University; Boston, MA, USA)
    Glycoengineering Cell Migration: Achieving the Promise of Cell Therapeutics
  • Tim Spector (Kings College London; London, United Kingdom)
    Integrated omic studies for common complex traits & personalized medicine
  • Chi-Huey Wong (Academia Sinica; Taipei, Taiwan)
    Glycosylation: chemical approach to disease biology


Confirmed Keynote Lecturers

  • Galit Alter (Ragon Institute of MGH, MIT, and Harvard; Cambridge, MA, USA)
    Programming B cell glycosylation via vaccination
  • Kiyoko Aoki-Kinoshita (Soka University; Tokyo, Japan)
    Utilizing the semantic WEB in GlyTouCan
  • Adam Barb (Iowa State University; Ames, IA, USA)
    The structural role of antibody N-glycosylation in receptor interactions
  • Frederic Bard (IMCB; Singapore, Singapore)
    Encoding the O-glycoproteome through Golgi reorganization
  • Nicolai Bovin (Shemyakin Institute of Bioorganic Chemistry, Russian Academy of Sciences;
    Moscow, Russia)
    Glycan binding specificity of highly pathogenic influenza viruses
  • Matthew Campbell (Department of Chemistry and Biomolecular Sciences, Macquarie University;
    Sydney, Australia)
    Data connectivity, the UniCarbKB way!"
  • Malcolm Dunlop (University of Edinburgh; Edinburgh, Scotland)
    Factors impacting on colorectal cancer risk and survival outcomes: Genes, environment and IgG glycosylation
  • Tamao Endo (Tokyo Metropolitan Institute of Gerontology; Tokyo, Japan)
    Glycosylation in muscular dystrophy
  • Sabine Flitsch (The University of Manchester; Manchester, UK)
    Structure-function studies of glycans using mass spectrometry
  • Michiko Fukuda (National Institute for Advanced Industrial Science and Technology; Tokyo, Japan)
    Targeted drug delivery by carbohydrate mimetic peptide overcomes blood brain barrier in mouse brain tumor models
  • Pascal Gagneux (University of California San Diego, Department of Pathology, Division of 
    Comparative Pathology and Medicine; La Jolla, CA, USA)
    Glycans and gene flow (reproductive and infectious)
  • Rita Gerardy-Schahn (Hannover Medical School, Institute for Cellular Chemistry; Hannover, Germany)
    The role of (poly)sialic acid in morphogenesis and organ function
  • Stuart Haslam (Imperial College London; London, UK)
    Glycomics and glycoproteomics: Powerful Technologies for Microbiology
  • Jun Hirabayashi (National Institute of Advanced Industrial Science and Technology; Tokyo, Japan)
    Investigation of a novel probe for pluripotent stem cells rBC2LCN and its applications to regenerative medicine
  • Rüdiger Horstkorte (Martin-Luther-University; Halle (Saale), Germany)
    Sialic acids and cancer: metabolic engineering as a potential strategy for therapy
  • Michael Jennings (Institute for Glycomics, Griffith University; Brisbane, Australia)
    Application of Glycan array analysis in the discovery of novel bacterial; host interactions
  • Kay-Hooi Khoo (Institute of Biological Chemistry, Academia Sinica; Taipei, Taiwan)
    Development and applications of advanced LC-MS/MS based glyco(proteo)mics
  • Ken Kitajima (Bioscience and Biotechnology Center, Nagoya University; Nagoya, Japan)
    Functional significance of glycan-mediated interactions on sperm microdomains during fertilization 
  • Daniel Kolarich (Max Planck Institute of Colloids and Interfaces, Dept. of Biomolecular Systems;
    Potsdam, Germany)
    Isomer specific glycan and glycopeptide sequencing as tools for unraveling disease glycosylation signatures
  • Gordan Lauc (University of Zagreb, Faculty of Pharmacy and Biochemistry, and
    Genos Glycoscience Research Laboratory, Zagreb, Croatia)
    High-throughput glycomics in patient stratification for personalized medicine
  • Dirk Lefeber (Radboud University Medical Center; Nijmegen, The Netherlands)
    Human genetic disease offers novel insights in protein glycosylation
  • Fu-Tong Liu (Academia Sinica; Taipei, Taiwan)
    Galectins in Innate Immunity
  • Haojie Lu (Department of Chemistry and Institutes of Biomedical Sciences; Key Laboratory of
    Glycoconjuates Research Ministry of Public Health.   (Fudan University); Shanghai, PRC China)
    Novel approaches for MS-based N-glycoproteome and N-glycome analysis
  • Anders Malmström (Lund University; Lund, Sweden)
    Function and Biosynthesis of Dermatan Sulfate
  • David Mills (University of California; Davis, CA, USA)
    A milk-oriented microbiota in breast fed infants: a glycan-driven microbial enrichment
  • Kelley Moremen (University of Georgia; Athens, GA, USA)
    Insights into the enzymology and structural biology of mammalian glycosylation enzymes coming from large-scale eukaryotic expression platforms
  • Falk Nimmerjahn (Institute of Genetics at the Department of Biology; Erlangen, Germany)
    Impact of glycosylation and immune complex size on immunoglobulin G activity
  • Shin-Ichiro Nishimura (Faculty of Advanced Life Science, Hokkaido University; Hokkaido, Japan)
    Epitope-defined antibodies as new class therapeutic and diagnostic reagents: toward personalized medicine from chemical glycobiology
  • Maja Pučić Baković (Genos Glycoscience Ltd; Zagreb, Croatia)
    Challenges of high-throughput glycomics - what to expect with large datasets
  • Niels Reichardt (CIC biomaGUNE; San Sebastián, Spain)
    Chemical Glycobiology of N-glycans: Tools and Applications
  • Celso Reis (Institute of Molecular Pathology and Immunology of the University of Porto; Porto, Portugal)
    Role of glycans in gastric cancer: functional and biomarker applications
  • Yuanyuan Ruan (Key Laboratory of Glycoconjugate Research Ministry of Public Health, School of
    Basic Medical Sciences, Fudan University; Shanghai, PRC China)
    O-GlcNAcylation of RACK1 promotes hepatocellular carcinogenesis
  • Lucia Renee Ruhaak (UT MD Anderson Cancer Center; Houston, TX, USA
    Glycans and Cancer: applications of mass spectrometry
  • Chihiro Sato (Bioscience and Biotechnology Center, Nagoya University; Nagoya, Japan)
    Structural and functional changes of polysialic acid related with genetic alterations of ST8SIA2 in psychiatric diseases
  • Inessa Schwab (University of Erlangen-Nürnberg; Erlangen, Germany)
    The role of sialylation in the anti-inflammatory activity of intravenous immunoglobulin
  • Sandro Sonnino (University of Milan, Department of Medical Biotechnology and Translational
    Medicine; Milan, Italy)
    Glycosphingolipids in health and diseases: the role of plasma membrane composition and organization
  • Pamela Stanley (Albert Einstein College of Medicine; New York, NY, USA)
    Roles for Glycans in Mammalian Development
  • Naoyuki Taniguchi (RIKEN, Wako, Japan)
    A keratin sulfate and its derivatives attenuate inflammation and the progression of emphysema in the murine lung by targeting to Langerin, C-type lectin
  • Ajit Varki (UC San Diego; San Diego, CA, USA)
    Siglecs: Discovery, Classification, Evolution and Functions
  • Gerd Wagner (King's College London, Department of Chemistry; London, UK)
    Glycosyltransferase inhibitors: Chemical tools for glycobiology
  • Maria Yazdanbakhsh (Leiden University Medical Center; Leiden, The Netherlands)
    Helminth glycans and TH2 responses
  • Alice Lin-Tsing Yu (Chang Gung Memorial Hospital at Linkou & Chang Gung University, Taoyuan; Taipei, Taiwan)
    Rationales and strategies for cancer immunotherapy targeting glycolipids
  • Xiao-Lian Zhang (Wuhan University School of Medicine, Dept. of Immunology, State Key Laboratory
    of Virology; Wuhan, PRC China)
    Immune evasion mediated by pathogen-glycans and related immunotherapy strategy
  • Vlatka Zoldos (Faculty of Science University of Zagreb; Zagreb, Croatia)
    Epigenetic regulation of protein glycosylation: implications for complex diseases
PCO: Spektar putovanja d.o.o.
A: Tkalciceva 15, 10000 Zagreb, Croatia
A: Mrs. Andrea Dragicevic
T: 00 385 1 4862 615
F: 00 385 1 4862 622
Event date: Sep 15-20, 2015
Abstr. submiss. deadline: CLOSED
All rights reserved, Spektar putovanja d.o.o.